Pradžia › Pjautinio ląstelės anemija › Texas › Houston

Pjautinio ląstelės anemija klinikiniai tyrimai Houston, TX

10 tyrimai dėl Pjautinio ląstelės anemija ieško dalyvių vietose Houston ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.

Oficialus tyrimo tekstas (anglų kalba)

Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

Renkami dalyviai3 fazė

Texas Childrens Cancer and Hematology Center, Houston
U of TX Health Science Ct, Houston

Amžius nuo 12 iki 100 · Visoms lytims · Atnaujinta 2026-09-28 · NCT06439082

A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

Renkami dalyviai3 fazė

Texas Children's Hospital_Houston, Houston
UT Health University of Texas, Houston

Amžius 2 ir vyresni · Visoms lytims · Atnaujinta 2026-09-18 · NCT06609226

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

Renkami dalyviai3 fazė

UT Health University of Texas, Houston

Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-09-17 · NCT06612268

A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease

Renkami dalyviai1/2 fazėLaukiami sveiki savanoriai

UT Health Science Center, Houston

Amžius nuo 12 iki 55 · Visoms lytims · Atnaujinta 2026-09-09 · NCT06546670

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

Renkami dalyviaiStebimasis tyrimas

Gulf States Hemophilia and Thrombophilia Center, Houston
Texas Children's Hemophilia & Thrombosis Center/Baylor College of Medicine, Houston

Visi amžiai · Visoms lytims · Atnaujinta 2026-08-17 · NCT04398628

The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease

Renkami dalyviai3 fazė

Baylor College of Medicine- Site Number : 8400055, Houston

Amžius nuo 10 iki 65 · Visoms lytims · Atnaujinta 2026-07-29 · NCT06975865

Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease

Renkami dalyviaiStebimasis tyrimas

Texas Children's Hopsital (NT-DMT), Houston
Texas Children's Hospital (MRD-HCT), Houston

Amžius nuo 3 iki 20 · Visoms lytims · Atnaujinta 2026-06-04 · NCT06941389

Study of a Single Dose of a 21-valent Pneumococcal Conjugate Vaccine in Children and Adolescents With Sickle Cell Disease

Renkami dalyviai3 fazė

Site # 8400004, Houston

Amžius nuo 2 iki 17 · Visoms lytims · Atnaujinta 2026-04-15 · NCT07247188

Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial

Renkami dalyviai2 fazė

Baylor College of Medicine, Houston

Amžius nuo 15 iki 40 · Visoms lytims · Atnaujinta 2026-03-13 · NCT06260891

Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease

Renkami dalyviaiStebimasis tyrimas

University of Texas at Houston, Houston

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-06-22 · NCT06385886

Pjautinio ląstelės anemija tyrimai kituose miestuose

Kiti tyrimai Houston

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.